SCHEMBL7555207

SCHEMBL7555207

C(=C\c1ccc2ccc3cccnc3c2n1)\c1ccc2ccccc2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.57
▸ RAB9A P51151 9/20 0.57
▸ NPC1 O15118 8/20 0.57
▸ LMNA P02545 7/20 0.57
▸ PKM P14618 2/20 0.57
▸ MAPT P10636 9/20 0.55
▸ TDP1 Q9NUW8 4/20 0.55
▸ SMN1; SMN2 Q16637 7/20 0.53
▸ HTT P42858 4/20 0.53
▸ NFKB1 P19838 2/20 0.53
▸ TP53 P04637 2/20 0.53
▸ GMNN O75496 1/20 0.53
▸ HSP90AA1 P07900 1/20 0.53
▸ MMP2 P08253 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ MMP9 P14780 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MMP8 P22894 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7555211 1.00 KDM4E (0.57) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL12068215 1.00 KDM4E (0.57) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL17899331 0.89 CCR1 (0.67) KDM4ERAB9ANPC1LMNAMAPT
SCHEMBL31300953 0.83 KDM4E (0.57) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL22501436 0.82 RAB9A (0.65) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL30494395 0.82 RAB9A (0.65) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL28443608 0.82 RAB9A (0.80) KDM4ERAB9ANPC1LMNAPKM
SCHEMBL21323727 0.81 L3MBTL1 (0.57) KDM4ERAB9ANPC1LMNAPKM
Quinoline SCHEMBL28850584 0.79 RAB9A (0.81) KDM4ERAB9ANPC1LMNAPKM
Phenanthroline SCHEMBL27546799 0.78 ALDH1A1 (0.77) KDM4ERAB9ANPC1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576540-A2 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Sunovion Pharmaceuticals Inc. (US) 2013-04-10 — — EP disclosed
WO-2011150156-A2 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-12-01 — — WO disclosed
Send feedback